111 – 120 of 174
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming
(
- Contribution to journal › Article
-
Mark
Cell reprogramming as a way to produce new functional neurons
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease : Dawn of a New Era
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Modeling Parkinson’s disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain
2017) In Proceedings of the National Academy of Sciences of the United States of America 114(39). p.8284-8293(
- Contribution to journal › Article
-
Mark
Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation
(
- Contribution to journal › Article
-
Mark
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model
(
- Contribution to journal › Letter
-
Mark
Term amniotic fluid : An unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications
(
- Contribution to journal › Article
-
Mark
Directly Converted Human Fibroblasts Mature to Neurons and Show Long-Term Survival in Adult Rodent Hippocampus
(
- Contribution to journal › Article
-
Mark
Preface
(
- Chapter in Book/Report/Conference proceeding › Foreword/Postscript
-
Mark
GFORCE-PD still going strong in 2016
(
- Contribution to journal › Scientific review